{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:56Z","timestamp":1787003636213,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Logistics Medical Key Specialty Project","award":["LQZD-SW"],"award-info":[{"award-number":["LQZD-SW"]}]},{"name":"the Fujian Provincial Science and Technology Program Science and Technology Innovation Platform Project","award":["2022Y2017"],"award-info":[{"award-number":["2022Y2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72944-5","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:05:01Z","timestamp":1726481101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk factor analysis and prediction model to establish recurrence or progression of non-functioning pituitary adenomas in men after transnasal sphenoidal surgery"],"prefix":"10.1038","volume":"14","author":[{"given":"Jiansheng","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangfeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shousen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"suppl_4","key":"72944_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom, Q. T. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol.20(suppl_4), iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131 (2018).","journal-title":"Neuro Oncol."},{"issue":"2","key":"72944_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5603\/EP.a2020.0011","volume":"71","author":"B Rak","year":"2020","unstructured":"Rak, B. et al. Pituitary tumours\u2014A large retrospective single-centre study of over 2300 cases. Experience of a tertiary reference centre. Endokrynol. Pol.71(2), 116\u2013125. https:\/\/doi.org\/10.5603\/EP.a2020.0011 (2020).","journal-title":"Endokrynol. Pol."},{"issue":"10","key":"72944_CR3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s12094-018-1868-6","volume":"20","author":"PD Delgado-L\u00f3pez","year":"2018","unstructured":"Delgado-L\u00f3pez, P. D., Pi-Barrio, J., Due\u00f1as-Polo, M. T., Pascual-Llorente, M. & Gord\u00f3n-Bola\u00f1os, M. C. Recurrent non-functioning pituitary adenomas: A review on the new pathological classification, management guidelines and treatment options. Clin. Transl. Oncol.20(10), 1233\u20131245. https:\/\/doi.org\/10.1007\/s12094-018-1868-6 (2018).","journal-title":"Clin. Transl. Oncol."},{"issue":"2","key":"72944_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s42000-020-00183-0","volume":"19","author":"D Margaritopoulos","year":"2020","unstructured":"Margaritopoulos, D. et al. Suprasellar extension independently predicts preoperative pituitary hormone deficiencies in patients with nonfunctioning pituitary macroadenomas: A single-center experience. Hormones (Athens).19(2), 245\u2013251. https:\/\/doi.org\/10.1007\/s42000-020-00183-0 (2020).","journal-title":"Hormones (Athens)."},{"issue":"1\u20132","key":"72944_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.wneu.2011.02.009","volume":"76","author":"AM M\u00fcsl\u00fcman","year":"2011","unstructured":"M\u00fcsl\u00fcman, A. M. et al. Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes. World Neurosurg.76(1\u20132), 141\u2013166. https:\/\/doi.org\/10.1016\/j.wneu.2011.02.009 (2011).","journal-title":"World Neurosurg."},{"issue":"3","key":"72944_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11102-011-0350-z","volume":"15","author":"CP Hofstetter","year":"2012","unstructured":"Hofstetter, C. P. et al. Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary.15(3), 450\u2013463. https:\/\/doi.org\/10.1007\/s11102-011-0350-z (2012).","journal-title":"Pituitary."},{"issue":"1","key":"72944_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/2014.3.JNS131679","volume":"121","author":"K Juraschka","year":"2014","unstructured":"Juraschka, K. et al. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: Institutional experience and predictors of extent of resection. J. Neurosurg.121(1), 75\u201383. https:\/\/doi.org\/10.3171\/2014.3.JNS131679 (2014).","journal-title":"J. Neurosurg."},{"issue":"5","key":"72944_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch, M. E. Diagnosis and treatment of pituitary adenomas: A review. JAMA.317(5), 516\u2013524. https:\/\/doi.org\/10.1001\/jama.2016.19699 (2017).","journal-title":"JAMA."},{"issue":"4","key":"72944_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000339823","volume":"96","author":"Y Chen","year":"2012","unstructured":"Chen, Y. et al. Natural history of postoperative nonfunctioning pituitary adenomas: A systematic review and meta-analysis. Neuroendocrinology.96(4), 333\u2013342. https:\/\/doi.org\/10.1159\/000339823 (2012).","journal-title":"Neuroendocrinology."},{"issue":"5","key":"72944_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1530\/EJE-11-0566","volume":"165","author":"R Reddy","year":"2011","unstructured":"Reddy, R., Cudlip, S., Byrne, J. V., Karavitaki, N. & Wass, J. A. Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?. Eur. J. Endocrinol.165(5), 739\u2013744. https:\/\/doi.org\/10.1530\/EJE-11-0566 (2011).","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"72944_CR11","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.21037\/jgo-23-138","volume":"14","author":"Y Dai","year":"2023","unstructured":"Dai, Y., Feng, Q. & Huang, J. A nomogram for predicting recurrence of primary hepatocellular carcinoma after resection. J. Gastrointest. Oncol.14(4), 1900\u20131901. https:\/\/doi.org\/10.21037\/jgo-23-138 (2023).","journal-title":"J. Gastrointest. Oncol."},{"key":"72944_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/IDR.S287852","volume":"14","author":"YN Ma","year":"2021","unstructured":"Ma, Y. N., Zhang, L. X., Hu, Y. Y. & Shi, T. L. Nomogram model for predicting the risk of multidrug-resistant bacteria infection in diabetic foot patients. Infect. Drug Resist.14, 627\u2013637. https:\/\/doi.org\/10.2147\/IDR.S287852 (2021).","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"72944_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-16-0173","volume":"175","author":"DS Olsson","year":"2016","unstructured":"Olsson, D. S., Bryngelsson, I. L. & Ragnarsson, O. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: A Swedish nationwide study. Eur. J. Endocrinol.175(1), 55\u201361. https:\/\/doi.org\/10.1530\/EJE-16-0173 (2016).","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"72944_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11102-018-0863-9","volume":"21","author":"M Tampourlou","year":"2018","unstructured":"Tampourlou, M., Fountas, A., Ntali, G. & Karavitaki, N. Mortality in patients with non-functioning pituitary adenoma. Pituitary.21(2), 203\u2013207. https:\/\/doi.org\/10.1007\/s11102-018-0863-9 (2018).","journal-title":"Pituitary."},{"issue":"7","key":"72944_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/nrendo.2016.82","volume":"12","author":"D Holmes","year":"2016","unstructured":"Holmes, D. Pituitary gland: Sex difference in comorbidity burden associated with nonfunctioning pituitary adenomas. Nat. Rev. Endocrinol.12(7), 374. https:\/\/doi.org\/10.1038\/nrendo.2016.82 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"72944_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete, O. & Lopes, M. B. Overview of the 2017 WHO classification of pituitary tumors. Endocr. Pathol.28(3), 228\u2013243. https:\/\/doi.org\/10.1007\/s12022-017-9498-z (2017).","journal-title":"Endocr. Pathol."},{"issue":"3","key":"72944_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00701-014-1993-0","volume":"156","author":"A \u0160te\u0148o","year":"2014","unstructured":"\u0160te\u0148o, A. et al. Nonfunctioning pituitary adenomas: Association of Ki-67 and HMGA-1 labeling indices with residual tumor growth. Acta Neurochir. (Wien).156(3), 451\u2013461. https:\/\/doi.org\/10.1007\/s00701-014-1993-0 (2014).","journal-title":"Acta Neurochir. (Wien)."},{"issue":"4","key":"72944_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"Micko, A. S., W\u00f6hrer, A., Wolfsberger, S. & Knosp, E. Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification. J. Neurosurg.122(4), 803\u2013811. https:\/\/doi.org\/10.3171\/2014.12.JNS141083 (2015).","journal-title":"J. Neurosurg."},{"issue":"1","key":"72944_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1042-3680(18)30831-3","volume":"1","author":"HJ Hoffman","year":"1990","unstructured":"Hoffman, H. J. Craniopharyngiomas. The role for resection. Neurosurg. Clin. N. Am.1(1), 173\u2013180 (1990).","journal-title":"Neurosurg. Clin. N. Am."},{"key":"72944_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2023.2203836","author":"R Flores-Rabasa","year":"2023","unstructured":"Flores-Rabasa, R. et al. Pre- and post-clinical-radiological and surgical evaluation of patients with pituitary adenoma and metabolic syndrome. Int. J. Neurosci.https:\/\/doi.org\/10.1080\/00207454.2023.2203836 (2023).","journal-title":"Int. J. Neurosci."},{"issue":"10444","key":"72944_CR21","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","volume":"403","author":"M Fleseriu","year":"2024","unstructured":"Fleseriu, M., Christ-Crain, M., Langlois, F., Gadelha, M. & Melmed, S. Hypopituitarism. Lancet.403(10444), 2632\u20132648. https:\/\/doi.org\/10.1016\/S0140-6736(24)00342-8 (2024).","journal-title":"Lancet."},{"issue":"1","key":"72944_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas, J. et al. A new prognostic clinicopathological classification of pituitary adenomas: A multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol.126(1), 123\u2013135. https:\/\/doi.org\/10.1007\/s00401-013-1084-y (2013).","journal-title":"Acta Neuropathol."},{"issue":"1","key":"72944_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema, F., Biermasz, N. R. & Pereira, A. M. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: A structured review and meta-analysis. Pituitary.15(1), 71\u201383. https:\/\/doi.org\/10.1007\/s11102-011-0347-7 (2012).","journal-title":"Pituitary."},{"issue":"2","key":"72944_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.21037\/gs-21-47","volume":"10","author":"W Lyu","year":"2021","unstructured":"Lyu, W., Fei, X., Chen, C. & Tang, Y. Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma. Gland Surg.10(2), 807\u2013815. https:\/\/doi.org\/10.21037\/gs-21-47 (2021).","journal-title":"Gland Surg."},{"key":"72944_CR25","doi-asserted-by":"publisher","DOI":"10.3171\/2018.5.JNS181054","author":"M Harary","year":"2021","unstructured":"Harary, M. et al. Endocrine function and gland volume after endoscopic transsphenoidal surgery for nonfunctional pituitary macroadenomas. J. Neurosurg.https:\/\/doi.org\/10.3171\/2018.5.JNS181054.","journal-title":"J. Neurosurg."},{"key":"72944_CR26","doi-asserted-by":"publisher","DOI":"10.3171\/2021.4.JNS21907","author":"RC Osorio","year":"2021","unstructured":"Osorio, R. C. et al. Socioeconomic predictors of case presentations and outcomes in 225 nonfunctional pituitary adenoma resections. J. Neurosurg.https:\/\/doi.org\/10.3171\/2021.4.JNS21907 (2021).","journal-title":"J. Neurosurg."},{"issue":"6","key":"72944_CR27","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2016-4061","volume":"102","author":"M Tampourlou","year":"2017","unstructured":"Tampourlou, M. et al. Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: A study from two large UK centers. J. Clin. Endocrinol. Metab.102(6), 1889\u20131897. https:\/\/doi.org\/10.1210\/jc.2016-4061 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"72944_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.1365-2265.2003.01784.x","volume":"58","author":"Y Greenman","year":"2003","unstructured":"Greenman, Y. et al. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: Markers of tumour quiescence and regrowth. Clin. Endocrinol. (Oxf).58(6), 763\u2013769. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01784.x (2003).","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"6","key":"72944_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00701-002-0938-1","volume":"144","author":"RA Kristof","year":"2002","unstructured":"Kristof, R. A. et al. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas. Acta Neurochir. (Wien).144(6), 555\u2013561. https:\/\/doi.org\/10.1007\/s00701-002-0938-1 (2002).","journal-title":"Acta Neurochir. (Wien)."},{"issue":"3","key":"72944_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/EJE-17-0965","volume":"178","author":"J Lelotte","year":"2018","unstructured":"Lelotte, J. et al. Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: A retrospective analysis of a monocentric cohort of 120 patients. Eur. J. Endocrinol.178(3), 237\u2013246. https:\/\/doi.org\/10.1530\/EJE-17-0965 (2018).","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"72944_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11102-010-0221-z","volume":"13","author":"EF Chang","year":"2010","unstructured":"Chang, E. F. et al. Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas. Pituitary.13(3), 223\u2013229. https:\/\/doi.org\/10.1007\/s11102-010-0221-z (2010).","journal-title":"Pituitary."},{"issue":"4","key":"72944_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp, E., Steiner, E., Kitz, K. & Matula, C. Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery.33(4), 610\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008 (1993).","journal-title":"Neurosurgery."},{"issue":"5","key":"72944_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11102-019-00976-6","volume":"22","author":"M Buchy","year":"2019","unstructured":"Buchy, M. et al. Predicting early post-operative remission in pituitary adenomas: Evaluation of the modified knosp classification. Pituitary.22(5), 467\u2013475. https:\/\/doi.org\/10.1007\/s11102-019-00976-6 (2019).","journal-title":"Pituitary."},{"issue":"1","key":"72944_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40618-020-01296-4","volume":"44","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro, M. et al. Predictive model of surgical remission in acromegaly: Age, presurgical GH levels and Knosp grade as the best predictors of surgical remission. J. Endocrinol. Invest.44(1), 183\u2013193. https:\/\/doi.org\/10.1007\/s40618-020-01296-4 (2021).","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"72944_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/02688697.2021.1884186","volume":"38","author":"L Yuhan","year":"2024","unstructured":"Yuhan, L., Zhiqun, W., Jihui, T. & Renlong, P. Ki-67 labeling index and Knosp classification of pituitary adenomas. Br. J. Neurosurg.38(2), 393\u2013397. https:\/\/doi.org\/10.1080\/02688697.2021.1884186 (2024).","journal-title":"Br. J. Neurosurg."},{"issue":"1","key":"72944_CR36","first-page":"320","volume":"12","author":"C Petry","year":"2019","unstructured":"Petry, C. et al. Evaluation of the potential of the Ki67 index to predict tumor evolution in patients with pituitary adenoma. Int. J. Clin. Exp. Pathol.12(1), 320\u2013326 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"72944_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s11102-019-00982-8","volume":"22","author":"AL Pappy 2nd","year":"2019","unstructured":"Pappy, A. L. 2nd. et al. Predictive modeling for pituitary adenomas: Single center experience in 501 consecutive patients. Pituitary.22(5), 520\u2013531. https:\/\/doi.org\/10.1007\/s11102-019-00982-8 (2019).","journal-title":"Pituitary."},{"issue":"8","key":"72944_CR38","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos, A., Schrag, D., Raj, G. V. & Panageas, K. S. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol.26(8), 1364\u20131370. https:\/\/doi.org\/10.1200\/JCO.2007.12.9791 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"72944_CR39","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: More than meets the eye. Lancet Oncol.16(4), e173\u2013e180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7 (2015).","journal-title":"Lancet Oncol."},{"issue":"4","key":"72944_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/genes15040483","volume":"15","author":"R Huang","year":"2024","unstructured":"Huang, R., Kong, Y., Luo, Z. & Li, Q. LncRNA NDUFA6-DT: A comprehensive analysis of a potential LncRNA biomarker and its regulatory mechanisms in gliomas. Genes (Basel).15(4), 483. https:\/\/doi.org\/10.3390\/genes15040483 (2024).","journal-title":"Genes (Basel)."},{"issue":"8","key":"72944_CR41","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/cancers16081465","volume":"16","author":"S Mokbel","year":"2024","unstructured":"Mokbel, S. et al. Development and validation of an inflammatory prognostic index to predict outcomes in advanced\/metastatic urothelial cancer patients receiving immune checkpoint inhibitors. Cancers (Basel).16(8), 1465. https:\/\/doi.org\/10.3390\/cancers16081465 (2024).","journal-title":"Cancers (Basel)."},{"issue":"1","key":"72944_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12864-024-10307-0","volume":"25","author":"L Ren","year":"2024","unstructured":"Ren, L. et al. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients. BMC Genomics.25(1), 413. https:\/\/doi.org\/10.1186\/s12864-024-10307-0 (2024).","journal-title":"BMC Genomics."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72944-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72944-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72944-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:18:40Z","timestamp":1726481920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72944-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72944"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72944-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4480469\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"26 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21607"}}